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increase offspring birth weight by 600 g when carried by the mother and reduce birth weight by 530 g when inherited by the fetus 14 .
To search for common genetic variants associated with birth weight, we performed a meta-analysis of GWA studies. We reasoned that finding such variants, even those with modest effects, would lead to enhanced understanding of pathways important for fetal growth and those underlying the associations between fetal growth and adult disease.
We meta-analyzed association statistics from 2,427,548 directly genotyped and imputed SNPs in singletons of European descent from six discovery GWA studies (n = 10,623; Supplementary Table 1 ). Birth weight was standardized to z scores within each study and adjusted for sex and gestational age. We observed SNPs at two independent loci on chromosome 3 that were associated with birth weight at, or close to, genome-wide significance (P < 5 × 10 −8 ; Supplementary Fig. 1 ). The first locus was at 3q25, between CCNL1 and LEKR1, and the second at 3q21 in ADCY5 (Fig. 1) . To replicate these associations, we genotyped the most strongly associated SNP from each locus (rs900400 from 3q25; rs9883204 from 3q21), or a closely correlated proxy (HapMap r 2 = 0.93-0.96), in 13 further samples of individuals of European descent (n = 27,591; Supplementary Table 2 ). Robust evidence of association was seen for both signals in these replication samples ( Fig. 2 ; P = 3 × 10 −26 and 3 × 10 −9 , respectively). Combining all discovery and replication samples, each additional C allele of SNP rs900400 (frequency 32-47%) was associated with a 0.086-s.d. lower birth weight (95% CI 0.073-0.100; P = 2 × 10 −35 ), whereas each C allele of SNP rs9883204 (frequency 71-83%) was associated with a 0.063-s.d. lower birth weight (95% CI 0.047-0.079; P = 7 × 10 −15 ; Table 1 ). These effect sizes equate to approximate differences of 40 g and 30 g per allele, respectively (median study s.d. = 484 g). Analysis conditional on the index SNPs, rs900400 and rs9883204 did not produce any evidence for additional independent signals at either locus.
We found no evidence of heterogeneity between the studies examined (P > 0.5; I 2 = 0%) 15 , despite differences in the distribution of birth weight over time and between populations ( Table 2) , and the associations with birth weight were similar in males and females (P > 0.05 for difference in effect sizes). Gestational age was not available as a covariate in three of our replication studies (combined n = 6,235; Supplementary Table 2 ), but these studies did not introduce detectable heterogeneity, and their removal from the meta-analysis changed the results very little ( Fig. 2 and Table 1 footnote). We also assessed the effects of the two SNPs on birth weight in a limited number of non-European or admixed samples from two studies (n = 1,415 Filipino subjects from the Cebu Longitudinal Health and Nutrition Survey, and n = 298-448 African-descended, Moroccan and Turkish subjects from Generation R; Supplementary Tables 2 and 3 ). There was no difference in the effect sizes observed relative to the European studies (P > 0.5), but the power to detect association was limited. Further well-powered studies will be needed to investigate these associations in non-Europeans. Results are from inverse variance, fixed-effects meta-analysis of all 19 study samples of European ancestry. The effect allele for each SNP is labeled on the positive strand according to HapMap. The effect is the change in phenotype z score per allele from linear regression, adjusted for sex and gestational age, assuming an additive genetic model. If the index SNP was unavailable, this was substituted with a closely correlated (HapMap r 2 > 0.9) proxy (rs1482853 or rs900399 for rs900400; rs2877716 or rs6798189 for rs9883204). There was no evidence of between-study heterogeneity of effect-size estimates (all P > 0.18; I 2 < 26%). a Index SNP rs900400, effect allele C (40% frequency in HapMap CEU; range 32-47% in our European study samples); nearest genes to the 3q25 signal are CCNL1 and LEKR1. b Index SNP rs9883204, effect allele C (73% frequency in HapMap CEU; range 71-83% in our European study samples); nearest gene to the 3q21 signal is ADCY5. c The P value for the birth-weight meta-analysis includes the double-genomic control correction of the discovery meta-analysis. d Excluding the three studies that were unable to adjust for gestational age, the β (s.e.m.), n and P values in the birth-weight analysis were -0.089 (0.008), n = 31,510, P = 7 × 10 -32 (3q25); -0.068 (0.009), n = 31,901, P = 8 × 10 -15 (3q21). e Ponderal index = birth weight/length 3 . Maternal and fetal genotypes are correlated as a result of segregation. In a previous study, an observed association between fetal TCF7L2 genotype and birth weight was driven by the effects of maternal TCF7L2 variation on the intrauterine environment rather than by a direct effect on fetal growth 16 . To distinguish between these two mechanisms, we tested whether the newly identified birth-weight associations were independent of maternal genotype. We genotyped both SNPs in all available maternal DNAs (n = 9,127; 5 study samples). Meta-analysis of associations between birth weight and fetal genotype, conditional on maternal genotype, yielded results that were very similar to the original associations at both loci (Supplementary Table 4) , showing that these are direct fetal effects. As expected, there was no association between fetal genotype and various covariates of birth weight that were not included in our main analysis (maternal smoking, body mass index (BMI), parity, education, age at delivery; all P > 0.05; data not shown).
Birth weight may be influenced by skeletal growth or fat mass. In available samples, we analyzed the association between each locus and birth length, birth head circumference and ponderal index ( Table 1 and Supplementary Figs. 2-4) . The association with ponderal index, relative to those with birth length and head circumference, was particularly strong for the rs900400 SNP (0.094 s.d. (95% CI 0.074-0.113) per C allele; P = 5 × 10 −21 ), suggesting that there is a greater association with fat mass than with skeletal growth. For the rs9883204 SNP, the measures showed more proportionate changes ( Table 1) . We investigated associations with adult height and BMI using published GWA meta-analyses from the GIANT consortium 17, 18 . Only the rs900400 signal was captured in the published height data at r 2 > 0.8 (because that study included direct genotypes from the Affymetrix Genechip 500k only), and we found no association (P = 0.64; n = 9,818). There was no association with adult BMI for either locus (n ≈ 32,500, P > 0.1). This is consistent with the weak observational association between birth weight and adult BMI 19 , indicating that they are largely governed by different processes.
Although birth weight is a continuous trait, standard clinical cutoffs are used to identify neonates who are small for gestational age and who may require further observation. We therefore assessed whether each SNP increased the odds of gestational age-adjusted birth weight <10 th percentile. Both loci were associated with smallness for gestational age: odds ratios (OR) 1.16 (95% CI 1.10-1.23) (n = 30,370; P = 1 × 10 −7 ) and 1.09 (1.02-1.16) (n = 30,778; P = 0.009) per C allele of rs900400 and rs9883204, respectively ( Supplementary Fig. 5 ).
The birth-weight signal marked by rs900400 maps approximately 35 kb 3′ to the LEKR1 locus (encoding leucine, glutamate and lysine rich 1) and 67 kb 3′ to CCNL1 (encoding cyclin L1). Neither gene has previously been implicated in fetal growth. The CCNL1 protein may be involved in pre-mRNA splicing and RNA processing and associates with cyclindependent kinases 20 . A noncoding RNA of unknown function, 682 bp from rs900400 (AK311218, Human March 2006 Assembly 18), overlaps with the signal. We found no evidence for association at a genomewide level (P > 5 × 10 −8 ) between our 3q25 birth-weight signal and mRNA expression in lymphocytes, using the publicly available 'mRNA by SNP Browser 1.0' 21 , and there was no association between rs900400 or rs900399 and type 2 diabetes or related adult glycemic traits in the recent GWA meta-analysis from the MAGIC consortium (P > 0.1) 1 . A range of approaches (including re-sequencing and functional studies) will be required to establish which gene-CCNL1, LEKR1 or another transcript-mediates the effect on fetal growth. the life course, with ADCY5 having a more marked effect in utero than the other loci. However, other mechanisms could be partially or wholly responsible for the association of ADCY5 with birth weight, including the regulation of placental glucose transporter expression 27 , vitamin B 2 uptake in the placenta 28 , and the architecture and permeability of the materno-fetal placental barrier 29 . The associations at 3q25 and 3q21 explained 0.3% and 0.1% of the variance in birth weight, respectively. Given that estimates of the fetal genetic contribution to birth weight from twin and family studies are generally between 10% and 40% 30, 31 , the proportion of heritability explained may be up to ten times greater. The variance explained by the first locus is comparable to that of maternal age (0.5%). We used a weighted risk allele score to estimate the differences in birth weight attributable to combinations of birth weight-lowering alleles at both loci. The 9% of Europeans with four birth weight-lowering alleles were, on average, 113 g (95% CI 89-137 g) lighter at birth than the 24% with zero or one allele (P for trend = 7 × 10 −30 ). For comparison, this effect on birth weight is similar to the impact of a mother smoking 4-5 cigarettes per day 4 and is approximately onethird of the impact of the severe malnutrition of the Dutch Famine of 1944-1945, during which pregnant women consumed, on average, <1,000 calories per day 32 .
To conclude, we have identified previously unknown, robust associations between fetal genotype and birth weight at loci near CCNL1 and at ADCY5. The causal mechanisms are not yet known, but the ADCY5 locus has pleiotropic effects on glucose regulation and type 2 diabetes in adulthood. This is robust evidence that the widely described association between lower birth weight and subsequent type 2 diabetes has a genetic component, distinct from the proposed role of programming
The second birth-weight locus at 3q21 (index SNP rs9883204) maps within ADCY5, encoding adenylyl cyclase 5. ADCY5 belongs to the family of enzymes responsible for the synthesis of cyclic adenosine monophosphate (cAMP) [22] [23] [24] . Allele A of rs11708067, which is in linkage disequilibrium (LD) with the birth weight-lowering C allele of rs9883204 (r 2 = 0.75), is associated with a higher risk of type 2 diabetes (OR 1.12 (95% CI 1.04-1.15); P = 9.9 × 10 −21 ; 40,655 cases/87,022 controls), higher fasting glucose (0.027 mmol/l (95% CI 0.021-0.033); P = 7.1 × 10 −22 ; n = 118,475) and reduced values of the Homeostatic Model Assessment (HOMA)-derived indices of beta-cell function (HOMA-B; P = 7.1 × 10 −12 ; n = 94,212) 1 , suggesting that it may influence insulin secretion. Fetal insulin is a key fetal growth factor, and these metabolic associations suggest that one mechanism explaining the ADCY5 association with birth weight might be a direct effect of the fetal risk allele on fetal growth via reduced insulin secretion, consistent with the fetal insulin hypothesis 11 .
However, our previous studies suggest that an association between fetal genotype and birth weight is not characteristic of all type 2 diabetes-associated loci. For example, susceptibility variants at CDKN2A-CDKN2B, IGF2BP2 and SLC30A8 and at TCF7L2 were not associated with birth weight in previous studies of n > 15,000, after adjusting for maternal genotype 12, 16 . To test this more comprehensively, we examined the associations between birth weight and all published type 2 diabetes-associated (n = 24) and fasting glucose-associated (n = 16) loci in our discovery GWA meta-analysis (n = 10,623) 1, 25, 26 . Only ADCY5 and CDKAL1 variants (the latter in line with previous reports 12, 13 ) showed evidence of association at P < 0.01 ( Supplementary Table 5 ). One explanation for the variable effects of different type 2 diabetes susceptibility loci on birth weight is that they may influence beta-cell function at different points of = 1,418) . The B58C-WTCCC and B58C-T1DGC were analyzed separately because they were genotyped on different platforms at different times. However, there is no systematic phenotypic difference between these subsamples. Genotypes were obtained using high-density SNP arrays and then imputed for ~2.4 million HapMap SNPs (Phase II, release 21/22; see URLs). The basic characteristics, exclusions (for example, individuals of non-European ancestry), genotyping, quality control and imputation methods for each discovery sample are presented in Supplementary Table 1 .
Statistical analysis within discovery samples. Multiple and preterm births (gestational age <37 weeks) were excluded from all analyses. Birth weight (BW) was transformed into a z score ([BW value -mean BW]/s.d. BW) to allow comparison of the data across studies. The overall (as opposed to sex-stratified) mean and s.d. from each study were used to create z scores. The association between each SNP and birth weight was assessed in each study sample using linear regression of birth-weight z score against genotype (additive model), with sex and gestational age as covariates. Imputed genotypes were used only where directly assayed genotypes were unavailable. In addition to this 'UNIFORM' analysis, a second analysis ('BEST') was performed, in which the analysis details were decided within each study. Details of the BEST analysis, GWA analysis software, and any additional corrections for study-specific population structure in the UNIFORM analysis are given in Supplementary Table 1 .
Meta-analysis of discovery samples. Data exchange was facilitated by the SIMBioMS platform (http://simbioms.org) 33 . Prior to meta-analysis, SNPs with a minor allele frequency <1% and poorly imputed SNPs (proper_info ≤0.4 (SNPTEST); r 2 ≤ 0.3 (MACH2QTL)) were filtered. Fixed-effects metaanalyses of the UNIFORM and BEST analyses were each run in parallel in two different study centers. Each was performed using different software packages: METAL (see URLs) and MetaMapper (developed in-house at Imperial College London, UK). Genomic control 34 was applied twice at the meta-analysis stage: first, to adjust the statistics generated within each cohort (see Supplementary  Table 1 for individual study λ values); and second, to adjust the overall metaanalysis statistics (λ = 1.032). The results from the UNIFORM analysis were meta-analyzed using the inverse-variance method, whereas for the BEST analysis a z score-weighted method that allows for differences in the units of β coefficients and standard errors was applied 35 . SNPs available for less than half of the total expected sample were excluded. Final meta-analysis results were obtained for 2,427,548 SNPs. Those SNPs that reached a P-value threshold of <10 −7 in the UNIFORM analysis (n = 10 SNPs, representing two distinct genomic regions on chromosome 3) were considered for further followup. The UNIFORM (reported here) and BEST analyses (data not shown) gave very similar results.
Checking for independent associations at the two loci. To test for the presence of additional association signals around the most strongly associated SNP in each region (rs900400 and rs9883204), we re-ran the UNIFORM association analysis on chromosome 3 in each discovery sample, including rs900400 and rs9883204 genotypes as additional covariates. Where these SNPs were imputed, genotype dosage was calculated from the genotype probabilities and used in the model. We meta-analyzed results using the inversevariance method.
Stage 2: followup of two lead signals in additional samples; followup samples, genotyping and analysis. We used 17 study samples (combined n = 30,098) to follow up the two lead signals from the GWA meta-analysis (represented by index SNPs rs900400 and rs9883204). Details of these samples are presented in Supplementary Table 2 . Thirteen of the samples (combined n = 27,591) were of European ancestry and were used for replication of the birth-weight associations. We also examined associations in four further non-European or admixed study samples (combined n = 2,507). Informed consent was obtained from all discovery and followup-study participants (or parental consent, as appropriate), and study protocols were approved by the local regional or institutional ethics committees. If the index SNP was unavailable, a closely correlated proxy was substituted (rs1482853 or rs900399 for rs900400 (HapMap r 2 = 1 and 0.96, respectively); rs2877716 or rs6798189 for rs9883204 (HapMap r 2 = 0.95 and 0.93, respectively)). In four of the replication studies, the index SNPs were imputed from genome-wide genotype data (see Supplementary Table 2 ). The UNIFORM birth-weight analysis (described above) was performed within each study sample. To investigate whether the associations were similar in the sexes, we repeated the analysis in males and females separately. 38 . Subsequently, each study defined SGA as below the tenth percentile of birth-weight SDS within their study population. We analyzed the associations between the two top hits and SGA using logistic regression. We combined the results across studies using fixed-effects inversevariance meta-analysis.
Meta
Combined allele score. To estimate the birth-weight effect sizes attributable to the two loci in combination, we created an allele score using information from both SNPs, which was weighted by effect size. This allowed us to estimate the differences in birth weight between individuals with different numbers of birth weight-lowering alleles at the two loci. We used nine European replication samples in which gestational age was available (n = 20,190). After verifying that the two SNPs were statistically independent, we generated the score using the formula where s j is score for individual j, g i,j is number of birth weight-lowering alleles (0, 1, 2) for SNP i carried by individual j and w i is effect size for SNP i from the UNIFORM analysis within the cohort. We performed linear regression of birth weight (in grams) against the allele score (additive model), with sex and gestation as covariates. We combined the coefficients from the nine studies using fixed-effects inverse-variance meta-analysis. We then rounded the weighted score to the nearest integer, grouping scores "0" and "1" together, and performed linear regression of birth weight against the rounded score as indicator variables, with sex and gestation as covariates. The β coefficients from the comparison of score 4 versus 0 or 1 in all nine studies were meta-analyzed (inverse variance, fixed effects). Variance explained. To estimate the percentage of variation in birth weight explained by each of the associated loci, we obtained the adjusted R 2 from univariate linear regression of birth weight against genotype. We then calculated a mean value from all European studies, weighted by sample size. For comparison, we also calculated the variance explained by variables such as gestational age, maternal age and smoking.
Analyses of potential confounders. To assess whether the associations were independent of maternal genotype, we used mother-offspring pairs from the five studies with both maternal and fetal genotype available (see Supplementary Table 4 ; total n = 8,880 for rs900400; n = 9,127 for rs9883204). Within each study, we performed the UNIFORM analysis, with maternal genotype as an additional covariate. For direct comparison, we repeated this without maternal genotype, using only subjects for whom maternal genotype was available. We performed two inverse variance meta-analyses (fixed effects) for each SNP, combining regression coefficients for (i) fetal genotype and (ii) fetal genotype adjusted for maternal genotype.
To verify that the SNPs were not associated with maternal covariates of birth weight that could theoretically confound the observed associations with birth weight (including maternal age, BMI, parity, smoking, pre-eclampsia and education), we used linear or logistic regression to model the association between each
